NEUROPATHIX, INC. Debt Conversion, Converted Instrument, Shares Issued
NEUROPATHIX, INC. reported Debt Conversion, Converted Instrument, Shares Issued of 2.00 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentSharesIssued1 · last filed 2022-05-23
- NEUROPATHIX, INC. debt conversion, converted instrument, shares issued for the quarter ending 2022-03-31 was 2.00M shares, a 46.92% decline year-over-year.
- NEUROPATHIX, INC. debt conversion, converted instrument, shares issued for the quarter ending 2021-03-31 was 3.77M shares.
| Period end | Debt Conversion, Converted Instrument, Shares Issued 0 month | Debt Conversion, Converted Instrument, Shares Issued 1 month | Debt Conversion, Converted Instrument, Shares Issued 2 month | Debt Conversion, Converted Instrument, Shares Issued 3 month |
|---|---|---|---|---|
| 2022-03-31 | 2.00M shares 10-Q · filed 2022-05-23 | |||
| 2021-03-31 | 3.77M shares 10-Q · filed 2022-05-23 | |||
| 2021-03-02 | 520.00K shares 10-Q · filed 2021-11-12 | |||
| 2021-02-10 | 243.69K shares 10-Q · filed 2021-11-12 | |||
| 2021-02-02 | 229.64K shares 10-Q · filed 2021-05-13 | |||
| 2021-02-01 | 517.67K shares 10-Q · filed 2021-11-12 | |||
| 2021-01-13 | 117.61K shares 10-Q · filed 2021-11-12 | |||
| 2021-01-12 | 175.00K shares 10-Q · filed 2021-11-12 | |||
| 2021-01-04 | 109.10K shares 10-Q · filed 2021-11-12 | |||
| 2020-12-18 | 70.97K shares 10-K · filed 2021-03-30 | |||
| 2020-11-23 | 122.05K shares 10-K · filed 2021-03-30 | |||
| 2020-11-16 | 90.00K shares 10-K · filed 2021-03-30 | |||
| 2020-10-23 | 40.73K shares 10-K · filed 2021-03-30 | |||
| 2020-10-13 | 64.42K shares 10-K · filed 2021-03-30 | |||
| 2020-09-24 | 46.90K shares 10-K · filed 2021-03-30 | |||
| 2019-09-26 | 1.50M shares 10-K · filed 2021-03-30 |